Analysts think ATYR stock price could increase by 1357%
Aug 11, 2024, 6:26 AM
3.85%
What does ATYR do
aTyr Pharma, Inc., headquartered in San Diego and founded in 2015, focuses on developing medicines by exploring the novel biological pathways of tRNA synthetases. Their main product, efzofitimod, aims to treat pulmonary sarcoidosis by targeting neuropilin-2 to alleviate chronic inflammation and fibrosis.
6 analysts think ATYR stock price will increase by 1357.14%. The current median analyst target is $26.52 compared to a current stock price of $1.82. The lowest analysts target is $16.16 and the highest analyst target is $36.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.